Cristina Ramona Cudalbu

photo placeholder image
Managing Director of 9.4T MRI Animal imaging and technology core - CIBM

CH F0 628 (Bâtiment CH)
Station 6
CH-1015 Lausanne

Données administratives



Current work

- In vivo studies of brain metabolism and edema in Hepatic Encephalopathy
- Hepatic Encephalopathy due to acute liver failure, chronic liver disease and hyperammonemia
- Chronic hepatic encephalopathy during brain development
- Animal models of Hepatic Encephalopathy and neuroprotection strategies
- Brain metabolites and macromlecules quantification
- Brain tumors
- In vivo proton, carbon and nitrogen MR Spectroscopy in small animals


2013-2017: Co-applicant in FP7-PEOPLE Marie Curie Initial Training Network project (Transforming Magnetic Resonance Spectroscopy into a Clinical Tool (TRANSACT))

2014: PI for the Industrial grant VSL Pharmaceuticals Inc.

2014-2016: Co-applicant in the Swiss Bridge Foundation application "Towards patient-specific treatments in glioblastoma: Comparison and validation of high-resolution imaging and molecular profiles of human glioblastoma and respective paired orthotopic xenografts in the mouse" (PI Andreas Hottinger)

2017-2018: Co-applicant in the Swiss Cancer League application “Characterizing invasiveness of patient derived brain tumor transplants in mice by gene expression profiling in association with metabolite profiles obtained by magnetic resonance spectroscopy (MRS). A pilot project”, (PI Monika Hegi)

2017-2021: Swiss National Science Foundation; grants n° 310030_173222/1 to Cudalbu&Braissant&McLin. “Translational Non-Invasive Metabolic Studies towards Novel Treatments of Chronic Hepatic Encephalopathy in Developing Brain, from 3D Organotypic Brain Cell Cultures to the In vivo Rat and Human Brain.”

2017-2021: Swiss National Science Foundation; grants n° 31003A-175778/1 to Braissant&Cudalbu. “Cerebral creatine deficiency syndromes: New in vivo AAV approaches to treat SLC6A8 deficiency.”